Brazil
Hospital Sirio-Libanes
Li-Fraumeni Syndrome, TP53 mutations, Cancer spectrum and risk, R337H variant, Genomics
Li-Fraumeni Syndrome, cost-effectiveness, TP53, cancer surveillance
Cancer, tumor-suppressor p53, Aggregation, Li-Fraumeni